Related Experiment Video
Updated: Sep 8, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
372
CAPOX vs. FOLFOX for Colorectal Cancer-Real World Outcomes in Ontario, Canada
Deepro Chowdhury1, Gregory R Pond2, John R Goffin3
1Windsor Regional Hospital, Windsor, ON N8W 2X3, Canada.
Current Oncology (Toronto, Ont.)
|August 27, 2025
Summary
In colorectal cancer treatment, CAPOX showed worse overall survival compared to FOLFOX, particularly in metastatic cases. Real-world data suggests careful patient selection is crucial for chemotherapy decisions.
Area of Science:
- Oncology
- Clinical Epidemiology
- Health Services Research
Background:
- Chemotherapy regimens like CAPOX and FOLFOX are standard for colorectal cancer (CRC).
- Limited real-world evidence (RWE) exists comparing their effectiveness and safety.
- Understanding RWE is crucial for optimizing CRC treatment strategies.
Purpose of the Study:
- To compare the real-world effectiveness of CAPOX versus FOLFOX in colorectal cancer patients.
- To analyze differences in Emergency Department visits/hospitalizations (ED/H) and overall survival (OS).
Main Methods:
- Analysis of a large Canadian provincial database (13,461 patients, 2005-2017).
- Comparison of outcomes between patients treated with CAPOX and FOLFOX.
- Multivariate analysis (MVA) to adjust for patient characteristics.
Main Results:
- CAPOX was used less frequently, often in older patients, and for shorter durations.
- Unadjusted ED/H rates were higher with CAPOX, but MVA showed no significant difference.
- CAPOX was associated with significantly worse overall survival (OS) in both non-metastatic and metastatic CRC.
Conclusions:
- CAPOX demonstrated inferior overall survival compared to FOLFOX in this real-world Canadian cohort.
- Factors like age, sex, comorbidities, and socioeconomic status also impacted survival.
- Findings underscore the importance of individualized treatment decisions and careful patient selection for CRC chemotherapy.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:24Kaplan-Meier Approach
254
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
254